Senior Director, Head of Vaccines & Antivirals RWE Strategic Planning

The position is for a seasoned individual contributor dedicated to supporting the development, digitization and evolution of an Integrated Evidence Plan, evolving that plan & incorporating into relevant governance documents, and other duties. The Head serve as single point of contact for all IEP readiness, strategic planning & tactical priority needs valuations, cohesive linkages between strategies/scenario plans to tactics to project plans, and recommends novel innovation & efficiency opportunities. They will be the Platform representative on all applicable franchise and asset governance across the lifecycle. They will monitor their performance and report metrics, challenges and opportunities back to the CMAO, Evidence Generation. Finally they will rapidly communicate successes, publications, external speaking engagements, and lessons learned to the EvGen Impact Translation lead. This leader will also work across EvGen Platform capabilities’ leaders including VPs and other Heads of Evidence Strategic Planning, Head of Business Operations, Vaccines / Antivirals team leads for RWE Clinical Affairs & Clinical Operations, Study Quality & Compliance, and RWE Platforms & Partnerships. Outside of the Platform, the colleague will work with senior executive leaders from R&D, Portfolio Management, CMAO, Medical Affairs Strategy, Biostatistics & Data Management, Global Regulatory Affairs, Clinical Pharmacology / Pharmacometrics, Market Access, Business Assessment & Development, Digital, Legal/Compliance, and others to achieve research and business objectives. They will also serve as an external face for Pfizer, providing expert epidemiological, statistical, methodological and execution excellence knowledge to the community. They will also serve as a trusted expert with study / analytical KOLs, key regulatory agencies (e.g., FDA in the US, EMA in Europe, MHRA in the UK, PDMA in Japan, CDE in China), HTAs/Payers, and other stakeholders as needed. ROLE RESPONSIBILITIES Create a vision for patient-centric early integrated evidence generation for the Pfizer enterprise at a global, regional and local level and ensure that the Platform at-large is delivering on the vision and ambition across teams Identifies, monitors and reports on KPIs Establish and maintain category-level RWE strategies, scenario and tactical plans, operating models, RWE valuation models, and quality control procedures in accordance with relevant Pfizer SOPs and industry best practices Responsible for oversight, quality and innovation of all prioritized global, regional and local studies Collaborates with CMAO and RWE Platforms & Partnerships colleagues, Clinical Scientists, Biostatistics, Statistical Programming and Digital to identify and fill RWD gaps using fit-for-purpose sources worldwide, incorporate advanced analytical and machine learning approaches, and scale innovations across category teams Leads through influence to build upon a culture of continuous learning & objective measurements activities for end-to-end evidence generation. Ensures that appropriate standards for cross-functional team-endorsed cohort definitions and business rules are digitized and disseminated to appropriate teams, versioning those rules to meet various use cases & ensuring that teams systematically incorporate these rules into their work for consistency across the lifecycle REQUIRED EXPERIENCE, TRAINING AND EDUCATION Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers and guide the work of other colleagues to achieve meaningful outcomes and create business impact. Advanced degree required, including MD, PhD. The incumbent must have at least 8 years’ experience with PhD or 5 years' experience with MD, hands‑on expertise and in leading teams with multiple of the following disciplines and approaches: site-based epidemiology, pharmacoepidemiology, database analysis, statistics, study design, basic science, clinical characteristics, pharmaceutical safety, pathophysiology, retrospective RWD sources, and RWE‑adjacent enabling technologies and approaches. Candidates who have only outsourced study design and execution need not apply. Direct experience as part of product development cross‑functional teams Ability to have spirited and direct scientific and operational discussions, seeking equitable decisions across all stakeholders A high degree of energy, enthusiasm and motivation for scientific discoveries Strong situational leadership skills & the ability to lead through influence Significant cross‑functional leadership/management experience including colleagues from different countries and cultures Leadership in a related scientific field, e.g., in professional societies, government, international bodies, etc. Global recognition as a scientific leader with e.g., 15+ scientific publications in peer‑reviewed journals and conference proceedings in areas relevant for the target assets Demonstration of a wide network of peers in a relevant disciplines (e.g., co‑authors and participation on professional societies, technical working groups, committees, etc.) Demonstrated ability to create and articulate global strategies, supervise & develop highly‑skilled and seasoned professionals, and to lead across diverse cultures and geographies through influence even in the absence of authority Able to act independently as well as cross‑functionally to achieve program goals Excellence in speaking/communicating publicly as evidenced by presentations at congresses, participation on committees/working groups, etc. Demonstrated strong work ethic, and proven track record of delivering high quality within timelines. Able to set priorities and manage cross‑functional teams and complex projects to deliver milestones according to set budgets. Ability to discuss scientific aspects of drug development, also comfortable in discussing commercial and regulatory issues. PREFERRED QUALIFICATIONS Successfully executed a major late phase development or post‑approval pharmaceutical product program. A blend of non‑pharmaceutical (academia, government, NGO) and pharmaceutical experience in relevant areas for target assets; pharmaceutical experience could be through partnerships or engagement in sponsored trials/studies rather than through employment Experience working with key regulatory agencies (FDA, EMA, MHRA, etc.) regarding pharmaceutical indication and/or labeling issues. Multiple languages Experiences overseeing or implementing studies in multiple settings globally (e.g., both developed and developing countries) Other Job Details Last Date to Apply for Job: February 16th, 2024 Travel of 20-50%, depending on budgets, organizational needs, and any other relevant restrictions LI-PFE The annual base salary for this position ranges from $226,200.00 to $377,000.00. In addition, this position is eligible for participation in Pfizer’s Global Performance Plan with a bonus target of 25.0% of the base salary and eligibility to participate in our share based long term incentive program. We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of life’s moments. Benefits offered include a 401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution, paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage. Learn more at Pfizer Candidate Site – U.S. Benefits | (uscandidates.mypfizerbenefits.com). Pfizer compensation structures and benefit packages are aligned based on the location of hire. The United States salary range provided does not apply to Tampa, FL or any location outside of the United States. Relocation assistance may be available based on business needs and/or eligibility. Sunshine Act Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider’s name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative. #J-18808-Ljbffr